Mazzari, Mario Attilio
 Distribuzione geografica
Continente #
NA - Nord America 2.469
EU - Europa 1.902
AS - Asia 1.858
SA - Sud America 292
AF - Africa 36
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 3
Totale 6.565
Nazione #
US - Stati Uniti d'America 2.413
SG - Singapore 985
DE - Germania 835
CN - Cina 386
SE - Svezia 279
BR - Brasile 248
FR - Francia 167
VN - Vietnam 134
UA - Ucraina 129
IT - Italia 125
GB - Regno Unito 117
IE - Irlanda 85
ID - Indonesia 63
IN - India 57
JP - Giappone 50
RU - Federazione Russa 41
FI - Finlandia 32
HK - Hong Kong 29
TR - Turchia 26
NL - Olanda 24
AR - Argentina 23
IQ - Iraq 23
BD - Bangladesh 21
CA - Canada 21
MX - Messico 21
PL - Polonia 20
ZA - Sudafrica 14
UZ - Uzbekistan 12
SA - Arabia Saudita 11
AT - Austria 10
ES - Italia 10
JO - Giordania 10
MA - Marocco 10
IR - Iran 8
PK - Pakistan 7
BE - Belgio 6
AE - Emirati Arabi Uniti 5
CH - Svizzera 5
EC - Ecuador 5
EU - Europa 5
KR - Corea 5
PH - Filippine 5
PY - Paraguay 5
KG - Kirghizistan 4
CL - Cile 3
JM - Giamaica 3
NP - Nepal 3
PE - Perù 3
PT - Portogallo 3
RO - Romania 3
VE - Venezuela 3
AL - Albania 2
AU - Australia 2
AZ - Azerbaigian 2
BY - Bielorussia 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
ET - Etiopia 2
HN - Honduras 2
IL - Israele 2
KE - Kenya 2
MN - Mongolia 2
PA - Panama 2
AM - Armenia 1
BB - Barbados 1
BG - Bulgaria 1
CG - Congo 1
CI - Costa d'Avorio 1
CO - Colombia 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EG - Egitto 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
MY - Malesia 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PR - Porto Rico 1
QA - Qatar 1
SN - Senegal 1
TH - Thailandia 1
TN - Tunisia 1
UY - Uruguay 1
Totale 6.565
Città #
Singapore 589
Chandler 443
San Jose 276
Ashburn 206
New York 117
Dublin 85
Beijing 82
San Mateo 79
Jacksonville 74
Nürnberg 61
Jakarta 56
Wilmington 52
Ho Chi Minh City 50
Lauterbourg 48
Tokyo 46
Los Angeles 45
Nanjing 45
Boston 40
Munich 35
Houston 34
Marseille 33
Hefei 32
Princeton 31
Chicago 30
Lancaster 30
Moscow 30
Ann Arbor 29
Frankfurt am Main 27
Hanoi 26
Buffalo 24
Dearborn 24
Milan 22
Seattle 20
São Paulo 20
Woodbridge 20
Lawrence 18
Hong Kong 17
Rome 17
Izmir 16
Norwalk 15
Nuremberg 15
Nanchang 14
Santa Clara 13
Hebei 12
Orem 12
University Park 12
Andover 11
Dallas 11
Johannesburg 11
Kent 11
Paris 11
Fairfield 10
Redwood City 10
San Francisco 10
Shanghai 10
Shenyang 10
Tashkent 10
Amman 9
Amsterdam 9
Baghdad 9
Kraków 9
Manchester 9
Montreal 9
Vienna 9
Washington 9
Zhengzhou 9
Chennai 8
Da Nang 8
Detroit 8
Helsinki 8
Bremen 7
Brooklyn 7
Düsseldorf 7
Memphis 7
Warsaw 7
Almere Stad 6
Atlanta 6
Bari 6
Berlin 6
Biên Hòa 6
Brussels 6
Cattolica 6
Kish 6
Mountain View 6
Rio de Janeiro 6
Salvador 6
Stockholm 6
The Dalles 6
Tyler 6
Augusta 5
Bexley 5
Busto Arsizio 5
Changsha 5
City of London 5
Denver 5
Hải Dương 5
Kunming 5
Leawood 5
London 5
Mexico City 5
Totale 3.424
Nome #
Renal artery stenting in patients with chronic ischemic heart disease 242
The HEART study: a real-world experience using the CID Chrono Carbostent in primary and rescue PCI 239
Management and timing of access-site vascular complications occurring after trans-radial percutaneous coronary procedures 233
Euroscore as predictor of in-hospital mortality after percutaneous coronary intervention 220
Outcome of non-cardiac surgery after stent implantation in the DES era: results of the Surgery After Stent (SAS) registry 217
Vascular complications and access crossover in 10,676 transradial percutaneous coronary procedures 209
Euroscore as predictor of in-hospital mortality after percutaneous coronary intervention 200
Procedural and clinical evaluation of the novel zotarolimus-eluting resolute stent in patients with unselected bifurcated coronary stenosis treated by provisional approach: a multicenter registry 197
Procedural and clinical evaluation of the novel zotarolimus-eluting resolute stent in patients with unselected bifurcated coronary stenosis treated by provisional approach: a multicenter registry 188
Prospective randomized comparison of sirolimus- or everolimus-eluting stent to treat bifurcated lesions by provisional approach 187
Selective Intracoronary injection of sestamibi to detect myocardial viability. Prediction of perfusion and contractile recovery after percutaneous transluminal coronary angioplasty 185
Coronary bifurcation lesions: to stent one branch or both? A meta-analysis of patients treated with drug eluting stents. 174
Maximal hyperemia in the assessment of fractional flow reserve: intracoronary adenosine versus intracoronary sodium nitroprusside versus intravenous adenosine: the NASCI (Nitroprussiato versus Adenosina nelle Stenosi Coronariche Intermedie) study 165
Baseline inflammatory status and long-term changes in renal function after percutaneous renal artery stenting: A prospective study 161
Influence of the amount of myocardium subtended by a stenosis on fractional flow reserve 158
Outcome of overlapping heterogenous drug-eluting stents and of overlapping drug-eluting and bare metal stents. 147
Management and timing of access-site vascular complications occurring after trans-radial percutaneous coronary procedures 142
Anomalous origin of coronary arteries from the "wrong" sinus in athletes: Diagnosis and management strategies. 142
Impact of the COVID-19 Pandemic on Enhanced Recovery After Surgery (ERAS) Application and Outcomes: Analysis in the “Lazio Network” Database 141
Transradial approach (left vs right) and procedural times during percutaneous coronary procedures: TALENT study 137
Restructuring surgical training after COVID-19 pandemic: A nationwide survey on the Italian scenario on behalf of the Italian polyspecialistic young surgeons society (SPIGC) 124
Baseline inflammatory status and long-term changes in renal function after percutaneous renal artery stenting: a prospective study 123
Outcome of non-cardiac surgery after stent implantation in the DES era: results of the Surgery After Stent (SAS) registry 117
Post-procedural renal microvascular perfusion measured using the Quantitative Blush Evaluator (QuBE) predicts improvement in renal function in patients undergoing percutaneous renal artery stenting 112
Provisional TAP-stenting strategy to treat bifurcated lesions with drug-eluting stents: one-year clinical results of a prospective registry. 107
Comparative assessment of mammalian target of rapamycin inhibitor-eluting stents in the treatment of coronary artery bifurcation lesions: the CASTOR-Bifurcation registry. 106
A pilot study with a new, rapid-exchange, thrombus-aspirating device in patients with thrombus-containing lesions: the Diver C.E. study. 97
Catheter-induced straightening of external iliac tortuosity: A cause of pseudostenosis to be borne in mind 94
Use of a novel high-osmolar gadolinium chelate, gadobutrol, for percutaneous renal artery stenting in two patients with chronic renal failure 94
Evaluation of a strategy for treating bifurcated lesions by single or double stenting based on the Medina classification. 94
Feasibility and long-term safety of elective Impella-assisted high-risk percutaneous coronary intervention: a pilot two-centre study 94
Transradial approach (left vs right) and procedural times during percutaneous coronary procedures: TALENT study. 93
Use of a second, "buddy" wire during percutaneous coronary interventions: A simple solution for some challenging situations 93
Percutaneous treatment of a large coronary aneurysm using the self-expandable symbiot PTFE-covered stent 92
Sodium bicarbonate plus N-acetylcysteine to prevent contrast-induced nephropathy in primary and rescue percutaneous coronary interventions: The BINARIO (BIcarbonato e N-Acetil-cisteina nell'infaRto mIocardico acutO) study 91
"Fogarty-like" removal of large coronary thrombus. 89
Adjunctive devices in primary or rescue PCI: A meta-analysis of randomized trials 88
Outcome of patients treated by a novel thin-strut cobalt-chromium stent in the drug-eluting stent era: Results of the SKICE (Skylor in real world practice) registry. 86
Glycoprotein IIB/IIIA inhibitor to reduce postpercutaneous coronary intervention myonecrosis and improve coronary flow in diabetics: The 'OPTIMIZE-IT' pilot randomized study 86
Directional atherectomy before stenting versus stenting alone in percutaneous coronary interventions: A meta-analysis. 85
Endothelin-1 and acute myocardial infarction: A no-reflow mediator after successful percutaneous myocardial revascularization 82
Baseline systemic inflammatory status and no-reflow phenomenon after percutaneous coronary angioplasty for acute myocardial infarction 81
Outcomes of the tacrolimus drug-eluting Janus stent: A prospective two-centre registry in high-risk patients 81
Comparison of the transradial and transfemoral approaches for coronary angiographic evaluation in patients with internal mammary artery grafts 77
Urgent PCI in patients with stent thrombosis: an observational single-center study comparing thrombus aspiration and standard PCI 73
Comparison of outcomes (early and six-month) of direct stenting with conventional stenting (a meta-analysis of ten randomized trials). 73
Rescue percutaneous coronary intervention for failed thrombolysis in a patient with anomalous coronary arteries 71
Angiographic evaluation of the effect of intracoronary abciximab administration in patients undergoing urgent PCI 66
Combined percutaneous pulmonary valvuloplasty and patent foramen ovale closure in an adult with recurrent transient ischemic attacks 65
Manual thrombus-aspiration improves myocardial reperfusion: The randomized evaluation of the effect of mechanical reduction of distal embolization by thrombus-aspiration in primary and rescue angioplasty (REMEDIA) trial 64
Selective intracoronary injection of sestamibi to detect myocardial viability: Perdiction of perfusion and contractile recovery after percutaneous transluminal coronary angioplasty 64
Sirolimus, Tacrolimus and Zotarolimus eluting stents to treat bifurcated lesions: a 7-month clinical outcome comparison 61
The complex link between oxidised low-density lipoprotein and unstable angina 60
Angiographics evalutation of the effect of intracoronary abciximab administration in patients undergoing urgent PCI 52
Endotelin-1 and acute myocardial infarction: a no-reflow mediator after successful percutaneous myocardial revascularization 43
Totale 6.662
Categoria #
all - tutte 27.881
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.881


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202111 0 0 0 0 0 0 0 0 0 0 0 11
2021/2022419 22 30 3 15 39 8 9 90 20 29 57 97
2022/20231.042 135 149 107 152 49 138 40 88 133 13 17 21
2023/2024530 21 132 16 12 20 145 15 4 14 21 69 61
2024/2025802 20 35 69 28 79 26 12 44 122 55 192 120
2025/20262.315 401 56 135 255 443 107 454 96 185 118 50 15
Totale 6.662